DK1051420T3 - Nye cytotoksiske tris(oxazol)-holdige makrolider - Google Patents

Nye cytotoksiske tris(oxazol)-holdige makrolider

Info

Publication number
DK1051420T3
DK1051420T3 DK99903797T DK99903797T DK1051420T3 DK 1051420 T3 DK1051420 T3 DK 1051420T3 DK 99903797 T DK99903797 T DK 99903797T DK 99903797 T DK99903797 T DK 99903797T DK 1051420 T3 DK1051420 T3 DK 1051420T3
Authority
DK
Denmark
Prior art keywords
represents hydrogen
lower alkyl
macrolides
oxazole
hydrogen
Prior art date
Application number
DK99903797T
Other languages
English (en)
Inventor
Tatsuo Instituto Biomar S Higa
Gravalos Dolores Instit Garcia
Jose Luis In Fernandez-Puentes
Original Assignee
Inst Biomar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biomar Sa filed Critical Inst Biomar Sa
Application granted granted Critical
Publication of DK1051420T3 publication Critical patent/DK1051420T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK99903797T 1998-01-27 1999-01-27 Nye cytotoksiske tris(oxazol)-holdige makrolider DK1051420T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9801741.1A GB9801741D0 (en) 1998-01-27 1998-01-27 New cytotoxic tris (oxazole)-containing macrolides
PCT/GB1999/000277 WO1999037653A1 (en) 1998-01-27 1999-01-27 New cytotoxic tris(oxazole)-containing macrolides

Publications (1)

Publication Number Publication Date
DK1051420T3 true DK1051420T3 (da) 2002-12-30

Family

ID=10825984

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99903797T DK1051420T3 (da) 1998-01-27 1999-01-27 Nye cytotoksiske tris(oxazol)-holdige makrolider

Country Status (21)

Country Link
US (1) US6391900B1 (da)
EP (1) EP1051420B1 (da)
JP (1) JP4511027B2 (da)
KR (1) KR20010034413A (da)
CN (1) CN1131869C (da)
AT (1) ATE229024T1 (da)
AU (1) AU760184B2 (da)
BR (1) BR9907748A (da)
CA (1) CA2319032C (da)
CZ (1) CZ291931B6 (da)
DE (1) DE69904294T2 (da)
DK (1) DK1051420T3 (da)
ES (1) ES2186324T3 (da)
GB (1) GB9801741D0 (da)
HU (1) HUP0101321A3 (da)
IL (1) IL137545A0 (da)
MX (1) MXPA00007381A (da)
PL (1) PL342040A1 (da)
PT (1) PT1051420E (da)
RU (1) RU2217433C2 (da)
WO (1) WO1999037653A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100471727B1 (ko) * 2002-10-14 2005-02-21 학교법인 포항공과대학교 이속사졸린 고리와 불소를 포함하는 거대고리 화합물 및그의 제조방법
CN100360515C (zh) * 2004-04-09 2008-01-09 中国科学院上海药物研究所 抗肿瘤活性成份陵水醇、制备方法和用途
JP2011526601A (ja) * 2008-07-03 2011-10-13 ファルマ・マール・ソシエダード・アノニマ 抗腫瘍性化合物
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6256493A (ja) * 1985-09-06 1987-03-12 Yamanouchi Pharmaceut Co Ltd カビラマイド類
CA2176011A1 (en) 1994-09-13 1996-03-21 Yoshiaki Nonomura Anti-hiv drug

Also Published As

Publication number Publication date
AU760184B2 (en) 2003-05-08
ATE229024T1 (de) 2002-12-15
KR20010034413A (ko) 2001-04-25
BR9907748A (pt) 2000-10-17
PL342040A1 (en) 2001-05-21
CA2319032A1 (en) 1999-07-29
JP4511027B2 (ja) 2010-07-28
CA2319032C (en) 2009-09-08
HUP0101321A2 (hu) 2001-09-28
JP2002501074A (ja) 2002-01-15
DE69904294T2 (de) 2003-08-21
AU2431999A (en) 1999-08-09
EP1051420B1 (en) 2002-12-04
EP1051420A1 (en) 2000-11-15
DE69904294D1 (de) 2003-01-16
MXPA00007381A (es) 2002-06-04
CN1320127A (zh) 2001-10-31
RU2217433C2 (ru) 2003-11-27
ES2186324T3 (es) 2003-05-01
PT1051420E (pt) 2003-02-28
CZ20002754A3 (cs) 2002-02-13
WO1999037653A1 (en) 1999-07-29
IL137545A0 (en) 2001-07-24
HUP0101321A3 (en) 2002-06-28
CZ291931B6 (cs) 2003-06-18
US6391900B1 (en) 2002-05-21
CN1131869C (zh) 2003-12-24
GB9801741D0 (en) 1998-03-25

Similar Documents

Publication Publication Date Title
NO20016401L (no) Th2 differensieringsinhibitorer
DK1037607T3 (da) Hidtil ukendt suppositoriumsform, der omfatter en syrelabil aktiv forbindelse
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
EP1404356A4 (en) CD10-ACTIVATED PRODRUG COMPOUNDS
MX9603050A (es) Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
NO995846L (no) Oksazolidinon-antibakterielle midler med en tiokarbonylfunksjonalitet
DK0949268T3 (da) Nye derivater af 2-fluor-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribohexopyranosyl)-oxy)-6-O-methyl-3-oxo-erythromycin, fremgangsmåde til deres fremstilling af deres anvendelse til syntese af aktive stoffer i medikamenter
MXPA03002911A (es) Compuestos quimicos.
DE60235274D1 (de) Octahydrobenzimidazolon-Verbindungen als Analgetika
AU2001266575A1 (en) Chemical compounds
GB9718903D0 (en) Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
EA200100347A1 (ru) Метод и композиция для лечения и профилактики туберкулеза
DK1051420T3 (da) Nye cytotoksiske tris(oxazol)-holdige makrolider
WO2002000638A8 (en) Substituted phthalides as anti-convulsive drugs
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
TW200505446A (en) Inhibitor of cox
SI1529777T1 (sl) Postopek inoksazolidinski intermediat za pripravo taksanov
DK1347984T3 (da) Fremgangsmåde til fremstilling af taxanderivater
AU3823800A (en) Compounds selectively inhibiting gamma 9 delta 2 t lymphocytes
YU55900A (sh) Postupak za sintezu inhibitora hiv proteaze
NO994902L (no) Forebygging av brystkreft ved selektive östrogenreseptormodulatorer
HK1061686A1 (en) Method of manufacturing substance gm-95
SG155066A1 (en) Oxetane compounds containing styrenic functionality
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
ATE313536T1 (de) Tetracyclische acetale